We could not find any results for: Make sure your spelling is correct or try broadening your search.
It looks like you aren't logged in.Click the button below to log in and view your recent history.
Already a member? Sign in
Interactive Brokers
Connect with traders and investors in our Follow Feed community.
Explore comprehensive options data and use advanced filters with Options Flow.
Organize and monitor your stock and asset watchlist with Monitor.
Please disregard the headline "FDA OKs Saphris For Schizophrenia and Bipolar Disorder" published at 10:45 a.m. EDT.
The news was reported in full at 7:30 a.m.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions